Genes in panel
STRs in panel
Prev Next
Regions in panel
Prev Next

BabyScreen+ newborn screening

Gene: MLYCD

Green List (high evidence)

MLYCD (malonyl-CoA decarboxylase)
EnsemblGeneIds (GRCh38): ENSG00000103150
EnsemblGeneIds (GRCh37): ENSG00000103150
OMIM: 606761, Gene2Phenotype
MLYCD is in 11 panels

3 reviews

John Christodoulou (Murdoch Children's Research Institute)

Green List (high evidence)

variable severity but has early onset; detected by NBS

Treatment is of some value; low fat/high ChO diet
Created: 1 Nov 2022, 4:55 a.m. | Last Modified: 1 Nov 2022, 4:55 a.m.
Panel Version: 0.719

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
hypoglycaemia; metabolic acidosis; cardiomyopathy; ID; seizures

Publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Green List (high evidence)

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Malonyl-CoA decarboxylase deficiency, MIM# 248360

David Amor (Murdoch Children's Research Institute)

Green List (high evidence)

Gene-disease association: Strong. Malonyl-CoA decarboxylase deficiency is an uncommon inherited metabolic disease. The characteristic phenotype is variable, but may include developmental delay in early childhood, seizures, hypotonia, diarrhea, vomiting, metabolic acidosis, hypoglycemia, ketosis, abnormal urinary compounds, lactic acidemia, and hypertrophic cardiomyopathy.

Onset: Infancy

Severity: severe

Treatment: Yes. If not detected by newborn screening, most cases of MLYCDD present with metabolic decompensation characterized by severe metabolic acidosis and hypoglycemia, associated with poor prognosis. As a result of expanded newborn screening, more patients with MLYCDD have been identified prior to the onset of symptoms, allowing for early initiation of treatment and potential prevention of complications such as hypoglycemia, cognitive impairment and cardiomyopathy.
Created: 4 Oct 2022, 2:25 a.m. | Last Modified: 4 Oct 2022, 2:25 a.m.
Panel Version: 0.274

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Malonyl-CoA decarboxylase deficiency

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • BabySeq Category A gene
Phenotypes
  • Malonyl-CoA decarboxylase deficiency, MIM# 248360
Tags
treatable metabolic
OMIM
606761
Clinvar variants
Variants in MLYCD
Penetrance
None
Panels with this gene

History Filter Activity

29 Dec 2022, Gel status: 3

Added Tag

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Tag metabolic tag was added to gene: MLYCD.

6 Oct 2022, Gel status: 3

Added Tag

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Tag treatable tag was added to gene: MLYCD.

6 Oct 2022, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: mlycd has been classified as Green List (High Evidence).

6 Oct 2022, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: MLYCD were changed from Malonyl-CoA decarboxylase deficiency to Malonyl-CoA decarboxylase deficiency, MIM# 248360

18 Sep 2022, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: MLYCD was added gene: MLYCD was added to gNBS. Sources: BabySeq Category A gene,Expert Review Green Mode of inheritance for gene: MLYCD was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: MLYCD were set to Malonyl-CoA decarboxylase deficiency